Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Progress in Heritable Skin Diseases: Translational Implications of Mutation Analysis and Prospects of Molecular Therapies
Acta Dermato-Venereologica, 06/24/09
Uitto J - Epidermolysis bullosa, a group of blistering disorders, serves as the paradigm of the tremendous progress made in understanding the molecular genetics of heritable skin diseases. Mutations in 10 distinct genes have been disclosed in the classic forms of epidermolysis bullosa, and the level of expression of the mutated genes within the cutaneous basement membrane zone, the types and combinations of mutations and their consequences at the mRNA and protein levels, when placed in the context of the individual's genetic background and exposure to environmental trauma, all determine the subtype and the phenotypic severity in each case.
Today in Autoimmune/Bullous Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Erysipeloid: a review
Clinical and Experimental Dermatology, 09/18/09
Skin fusion on the fingers and toes of an adolescent girl
The Clinical Advisor, 09/10/09
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up
Clinical and Experimental Dermatology, 11/02/09
C-Kit (CD117) expression in classic Kaposis sarcoma
Clinical and Experimental Dermatology, 11/02/09
Repeated episodes of fixed eruption 3 months after discontinuing pegylated interferon-alpha-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection
Clinical and Experimental Dermatology, 10/16/09
Sponsor
Article Search
Sponsor


See Latest Articles


